후천성 림프부종 동물모델의 개발과 치료적 적용
Received: Apr 04, 2017; Accepted: Jun 06, 2017
Published Online: May 31, 2017
Abatract
Acquired lymphedema is the serious side-effect caused by lymphatic disorder through aggressive cancer therapy. Although a high incidence of acquired lymphedema after cancer treatment has been reported in various types of cancer, there is no definite cure to reduce lymphedema, prevent infection, and reduce complications due to the lack of understanding in the biology of lymphedema development. A reliable and reproducible animal model is required to understand the molecular mechanisms involved in lymphedema formation and to study new therapeutic approaches for lymphedema. Therefore, we developed the lymphedema mice showing high reliability and reproducibility through damages of the specific combination including lymph nodes and lymphatic vessels. This novel acquired lymphedema animal could provide the standard model system to study lymphedema therapies.
Metrics
QR Code of this Article:
Related Articles
Photo-physical and -Chemical Effects of Low-level LASER on Lymphedema Treatment
Clin. Lymphology Lymphedema 2025;10(2):31-35.
Change of Tissue and Microenvironment Following Lymphatic Injury
Clin. Lymphology Lymphedema 2023;8(1):12-15.
Innovative Artificial Lymphatic Structures for Lymphedema Treatment and Prevention
Clin. Lymphology Lymphedema 2023;8(1):1-7.
New Treatment Concepts for the Treatment of Secondary Lymphedema
Clin. Lymphology Lymphedema 2019;4(2):23-26.
Pharmacological Management of Lymphedema
Clin. Lymphology Lymphedema 2017;2(2):31-35.
